FNO
Desconocido
STOPSTORM: A PROSPECTIVE EUROPEAN VALIDATION COHORT FOR STEREOTACTIC THERAPY OF RE ENTRANT TACHYCARDIA
FAKULTNI NEMOCNICE OSTRAVA
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Ventricular tachycardia (VT) is an unpredictable and potentially deadly condition and should be promptly treated with catheter ablation and...
2021-01-21 - 2027-04-30 | Financiado
2021-01-21 - 2027-04-30 | Financiado
PillSense: Accelerating market introduction of the first real time diagnistic and monitoring device for upper g...
FAKULTNI NEMOCNICE OSTRAVA
participó en un
H2020:
H2020-EIC-FTI-2018-2020
Upper gastrointestinal bleeding (UGIB) is a potentially life-threatening condition that affects approx. 2 million people annually in Europe...
2018-12-07 - 2021-06-30 | Financiado
2018-12-07 - 2021-06-30 | Financiado
EURE-CART: EURopean Endeavour for Chimeric Antigen Receptor Therapies
FAKULTNI NEMOCNICE OSTRAVA
participó en un
H2020:
H2020-SC1-2016-2017
Cancer is rapidly becoming the most frequent cause of death in EU. Though enormously expensive (several billions EUR/year), currently availa...
2016-12-05 - 2021-06-30 | Financiado
2016-12-05 - 2021-06-30 | Financiado
THE HIP TRIAL: Management of Hypotension In the Preterm Extremely Low Gestational Age Newborn
FAKULTNI NEMOCNICE OSTRAVA
participó en un
FP7:
Assuming an annual birth rate of 10.25 births/1,000 population approximately 25,000 Extremely Low Gestational Age Newborns are born every ye...
Financiado
Financiado
* No se disponen de datos de la empresa actual.